C12 N4 H20 - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

4693-47-4

4,4'-偶氮双(4-氰基戊醇)

4,4'-Azobis(4-cyano-1-pentanol);
2-(2-Cyano-5-hydroxy-pentan-2-yl)diazenyl-5-hydroxy-2-methyl-pentanenitrile

人α-ANF(I-28)

Atrial natriureticpeptide-28 (human reduced) (9CI);
Atriopeptin-33(rat reduced), 1-de-L-leucine-2-de-L-alanine-3-deglycine-4-de-L-proline-5-de-L-arginine-17-L-methionine-;
13: PN: WO2004089280 SEQID: 13 unclaimed sequence;
13: PN: WO2005103087 SEQID:16 unclaimed sequence;
140: PN: WO2008058016 SEQID: 141 claimed protein;
15:PN: US20030119021 SEQID: 14 unclaimed sequence;
15: PN: WO2008154226 SEQID: 15unclaimed protein;
16: PN: WO0071576 SEQID: 16 unclaimed sequence;
18: PN:WO2004022003 SEQID: 4 claimed sequence;
18: PN: WO2005094420 SEQID: 4 claimedsequence;
19: PN: WO2007034498 SEQID: 18 unclaimed sequence;
1: PN: DE19942230SEQID: 6 claimed protein;
1: PN: US20030069186 SEQID: 5 unclaimed sequence;
1:PN: US20090163421 SEQID: 1 unclaimed sequence;
1: PN: WO0185945 SEQID: 1unclaimed sequence;
2145: PN: WO03060071 SEQID: 2207 unclaimed;
21: PN:WO2004045592 SEQID: 20 unclaimed sequence;
220: PN: US20060293232 PAGE: 14unclaimed sequence;
294: PN: WO0069900 SEQID: 476 unclaimed sequence;
2: PN:GB2403533 SEQID: 2 claimed sequence;
2: PN: WO02074234 FIGURE: 3B claimedprotein;
301: PN: US20080004206 SEQID: 302 unclaimed protein;
313: PN:WO0069900 SEQID: 495 unclaimed sequence;
38: PN: WO2005003296 SEQID: 309unclaimed sequence;
393: PN: US20090175821 SEQID: 476 claimed protein;
3: PN:CN1278007 SEQID: 5 unclaimed sequence;
3: PN: US20080194481 SEQID: 302 claimedprotein;
439: PN: US20080312157 SEQID: 456 unclaimed sequence;
4: PN:US20080214437 SEQID: 4 claimed protein;
4: PN: WO2009073527 SEQID: 4 claimedprotein;
4: PN: WO2009142307 SEQID: 100 claimed protein;
5-32-Urodilatin(human);
59: PN: US6033884 SEQID: 53 unclaimed protein;
5: PN: WO2007035600SEQID: 3 unclaimed sequence;
604: PN: WO2009058322 SEQID: 302 claimed sequence;
78: PN: WO03099862 PAGE: 45 unclaimed protein;
7: PN: US20060183154 SEQID: 7claimed sequence;
95: PN: WO2007047504 SEQID: 179 unclaimed sequence;
99-126-natriuretic hormone peptide (human);
9: PN: US20010027181 SEQID: 1unclaimed protein;
Atriopeptin-28 (Canis familiaris reduced);

Atrial natriureticpeptide-28 (rat reduced) (9CI);
Atriopeptin-33(rat reduced), 1-de-L-leucine-2-de-L-alanine-3-deglycine-4-de-L-proline-5-de-L-arginine-;
10: PN: US20010027181 SEQID: 2 unclaimed sequence;
26: PN: US20070049521 SEQID:26 claimed sequence;
304: PN: WO0069900 SEQID: 486 unclaimed sequence;
3: PN:WO2004056970 TABLE: 1 unclaimed sequence;
403: PN: US20090175821 SEQID: 486claimed protein;
7: PN: WO2008036970 FIGURE: 2 unclaimed sequence;
Atrialnatriuretic peptide (6-33);
Atriopeptin-28 (rabbit reduced);
Cardionatrin I(rat reduced);
L-Tyrosine,L-seryl-L-leucyl-L-arginyl-L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-

Brain natriureticpeptide-26 (swine reduced) (9CI);
Natriureticfactor-26 (pig brain reduced);
329: PN: WO0069900 SEQID: 511 unclaimedsequence;
424: PN: US20090175821 SEQID: 511 claimed protein;
8: PN:WO2008036970 FIGURE: 2 unclaimed sequence;
L-Tyrosine, L-a-aspartyl-L-serylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-arginyl-L-arginyl-L-leucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-seryl-L-leucyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-valyl-L-leucyl-L-arginyl-L-arginyl-;
Porcine brain natriuretic peptide

1,4-PB-ITU 二氢溴酸盐

Carbamimidothioic acid,C,C'-(1,4-phenylenedi-2,1-ethanediyl) ester, hydrobromide (1:2);
Carbamimidothioicacid, 1,4-phenylenedi-2,1-ethanediyl ester, dihydrobromide (9CI);
PBIT

Cytidine5'-(trihydrogen diphosphate), P'-[2-(formylhydroxyamino)ethyl] ester (9CI);
AntibioticTAN 1022A;
Fosfocytocin

Guanidine,N-[3-(aminomethyl)-4-ethylphenyl]-N'-ethyl-;
Guanidine, N-[3-(aminomethyl)-4-ethylphenyl]-N-ethyl- (9CI)

Hydrazinecarboximidamide,2-[2-(2,4,6-trimethylphenyl)ethyl]-;
Guanidine,[(2,4,6-trimethylphenethyl)amino]- (8CI)

Hexanamide, 2,6-diamino-N-(4-nitrophenyl)-, hydrobromide (1:2), (2S)-;
Hexanamide, 2,6-diamino-N-(4-nitrophenyl)-, dihydrobromide, (2S)- (9CI);
Hexanamide,2,6-diamino-N-(4-nitrophenyl)-, dihydrobromide, (S)-;
L-Lysine p-nitroanilide dihydrobromide

Pentanenitrile,2-[(1-cyano-3-methylbutyl)azo]-2-methyl- (9CI);
Valeronitrile,2,4'-dimethyl-2,2'-azodi- (8CI)

Pyrrolo[2,3-c]pyrazole,3-(1-ethyl-4-piperidinyl)-1,4,5,6-tetrahydro-;
Pyrrolo[2,3-c]pyrazole, 3-(1-ethyl-4-piperidinyl)-1,4,5,6-tetrahydro- (9CI)

Pyrrolo[2,3-c]pyrazole,3-(1-ethyl-3-piperidinyl)-1,4,5,6-tetrahydro-;
Pyrrolo[2,3-c]pyrazole, 3-(1-ethyl-3-piperidinyl)-1,4,5,6-tetrahydro- (9CI)

Pyrrolo[2,3-c]pyrazole,3-(1-ethyl-2-piperidinyl)-1,4,5,6-tetrahydro-;
Pyrrolo[2,3-c]pyrazole, 3-(1-ethyl-2-piperidinyl)-1,4,5,6-tetrahydro- (9CI)

1-Piperazinepropanamide,4-(2-pyridinyl)-, hydrochloride (1:2);
1-Piperazinepropanamide,4-(2-pyridinyl)-, dihydrochloride (9CI)

1H-1,4-Diazepine,1-(2,6-dimethyl-3-nitro-1-oxido-4-pyridinyl)hexahydro-, hydrochloride (1:2);
1H-1,4-Diazepine,1-(2,6-dimethyl-3-nitro-1-oxido-4-pyridinyl)hexahydro-, dihydrochloride (9CI);
1H-1,4-Diazepine, 1-(2,6-dimethyl-3-nitro-4-pyridinyl)hexahydro-, N-oxide,dihydrochloride

ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-IL

(ALA11,D-LEU15)-OREXIN B (HUMAN);
ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2;
H-ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2;
[ALA11,D-LEU15]-OREXIN B;
(ALA11,D-LEU15)-OREXIN B (HUMAN);
H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2;
M.W. 2857.28 C120H206N44O35S

ANF (1-28), RAT

ATRIAL NATRIURETIC FACTOR (1-28) (RAT);
ANF (123-150), RAT;
ANF (1-28), RAT;
ANF 1-28;
ANP (RAT, 1-28) (RABBIT, MOUSE);
ANP 1-28, RAT;
ANP (123-150), RAT;
ALPHA-ATRIOPEPTIN, RAT;
ALPHA-ANF 1-28, RAT

3，3’-二氨基联苯胺

DAB 4HCl;
3,3'-Diaminobenzidine Tetrahydrochloride Hydrate [for Biochemical Research];
3,3μ-Diaminobenzidine hydrate tetrahydrochloride;
3,3'-DIAMINOBENZIDINE TETRAHYDROCHLORIDE HYDRATE, CONTAINS UP TO 10% WATER, 97%;
3,3'-Diaminobenzidine tetrahydrochloride hydrate,97%,contains up to 10% water;
DAB，hydrate;
3,3′-Diaminobenzidine tetrahydrochloride,3,3′,4,4′-Biphenyltetramine tetrahydrochloride, 3,3′,4,4′-Tetraaminobiphenyl tetrahydrochloride, DAB;
Diaminobenzidine-4HCl-xH2O

无

(TYR43)-PTH (43-68) (HUMAN)

(TYR43)-PTH (43-68) (HUMAN);
H-TYR-ARG-ASP-ALA-GLY-SER-GLN-ARG-PRO-ARG-LYS-LYS-GLU-ASP-ASN-VAL-LEU-VAL-GLU-SER-HIS-GLU-LYS-SER-LEU-GLY-OH;
PARATHYROID HORMONE [TYR43]-HUMAN: FRAGMENT 43-68;
[TYR43] PARATHYROID HORMONE (43-68), HUMAN;
(TYR43)-PTH (43-68) (HUMAN);
tyr43-parathyroid hormone fragment*43-68 human se;
TYR43-PARATHYROID HORMONE FRAGMENT*43-68 HUMAN SEQU;
[tyr43]-pth fragment 43-68 human;
tyr-arg-asp-ala-gly-ser-gln-arg-pro-arg-lys-lys-glu-asp-asn-val-leu-val-glu-ser-his-glu-lys-ser-leu-gly

卡培立肽;
卡培立肽;
SER-LEU-ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-MET: O-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR[SLRRSSCFGGR-MET: O-DRIGAQSGLGCNSFRY]DISULFIDE BRIDGE CYS7-CYS23.;
醋酸卡培立肽 89213-87-6

ANP 1-28, HUMAN;
ATRIAL NATRIURETIC PEPTIDE HUMAN;
ATRIAL NATRIURETIC PEPTIDE HUMAN, 1-28;
ATRIAL NATRIURETIC PEPTIDE 1-28, HUMAN;
ATRIAL NATRIURETIC PEPTIDE (1-28), HUMAN, PORCINE;
ATRIAL NATRIURETIC FACTOR 1-28, HUMAN;
ATRIAL NATRIURETIC FACTOR (1-28) (HUMAN, CANINE);
ATRIAL NATRIURETIC FACTOR (1-28) (HUMAN, PORCINE);
ANP, ALPHA-, HUMAN

C127H203N45O39S3

详情

供应商

化工产品